1 2 3 4 5 Next
Murdock Research Institute offers free classes
KANNAPOLIS — The David H. Murdock Research Institute will present a series of free public seminars about how technologies in the Core Lab are used to ... (Sun, 01 Nov 2009 08:20:51 GMT)
Of God and Grants
The blogger at Medical Writing, Editing & Grantsmanship notes that 18,000 applications came in for challenge grants, with 11,000 more in the error correction queue. (Sun, 01 Nov 2009 12:15:38 GMT)
UI prof has unique perspective on genome
URBANA – University of Illinois Professor Richard Powers was doing research for his 10th novel when GQ magazine made him an offer he couldn't refuse. Its editors asked him to have his own genome sequenced and analyzed and to write an article about it. He really didn't want to know his medical future but accepted the assignment; the novel he was working on was about genomics, among other themes. (Sun, 01 Nov 2009 15:05:42 GMT)
Guru Stocks at 52-Week Low: GILD, MON, RAH, PCS, LEAP
By guruyt. Last week's top five stocks that reached their 52-week lows were Gilead Sciences Inc, Monsanto Company, Ralcorp Holdings Inc, MetroPCS Communications Inc, and Leap Wireless International Inc. According to GuruFocus updates, these Guru stocks have reached their 52-week lows. Read more » » (Sun, 01 Nov 2009 15:57:33 GMT)
WCMC-Q's biomedical research program makes significant progress
The biomedical research program of Weill Cornell Medical College in Qatar has made significant progress in its dual goals of advancing basic science and building a sustainable research community in Qatar since it was launched less than a year and a half ago. (Mon, 02 Nov 2009 05:58:31 GMT)
Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. (Mon, 02 Nov 2009 06:43:53 GMT)
MEDomics New MitoDx Test for Mitochondrial Diseases Featured at Major Scientific Meeting in Taiwan
The MitoDx test is much more accurate than any test currently available and will aid in the detection of mitochondrial diseases. (Mon, 02 Nov 2009 07:00:00 GMT)
Lupus Drug Shows Promise in New Trial
Human Genome Sciences said early Monday that its experimental drug to treat lupus was effective in its second big clinical trial. (Mon, 02 Nov 2009 07:05:30 GMT)
Tumour tissue: who is in control?
Recent developments in genomics have resulted in the increased availability of gene profiles for early diagnosis and prognosis in breast cancer. (Mon, 02 Nov 2009 10:06:37 GMT)
NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON’s second drug candidate entering the clinical stage of development within only five months. (Mon, 02 Nov 2009 10:13:31 GMT)
As swine flu vaccine runs dry, US wonders 'what if?'
Mothers with young children and pregnant women are being turned away from swine flu vaccination clinics in the United States, some in tears, many utterly frustrated by the shortage of vaccine. (Mon, 02 Nov 2009 10:30:03 GMT)
Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases
SUNNYVALE, CA--(Marketwire - 11/02/09) - Arrayit Corporation (OTC.BB: ARYC - News ) is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform. For more than 150 years, traditional medicine has relied on a 'standards of care' model, which utilizes large cohorts of individuals as the data set and ... (Mon, 02 Nov 2009 12:00:00 GMT)
Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases
Collaborative Efforts Leading to Advances That Will Reduce Health Care Costs (Mon, 02 Nov 2009 12:09:50 GMT)
GenePattern, DNA Analytics 4.0, SynaWorks, CELS@Home
The Broad Institute has released GenePattern 3.1 , which includes more than 100 modules for the analysis of gene expression, genetic variation, pathways, and proteomics data. (Mon, 02 Nov 2009 12:15:52 GMT)
Calling for an Explanation
A bunch of bloggers are still waiting on editor-in-chief Michael Dunn's explanation of what occurred during the review and editing process at Proteomics to allow Ward and Han's ' Mitochondria, the missing link between body and soul: Proteomic prospective evidence ' paper to be published. (Mon, 02 Nov 2009 12:16:22 GMT)
Institute for Systems Biology to Work With Complete Genomics to Conduct Large-Scale Huntington's Disease Study
SEATTLE & MOUNTAIN VIEW, Calif.----The Institute for Systems Biology and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington’s disease . (Mon, 02 Nov 2009 13:00:00 GMT)
Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis
MADISON, Wis.----Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop series in four European cities and seven cities in Asia Pacific. (Mon, 02 Nov 2009 13:00:00 GMT)
FDA Clears SQI's Automated SQiDworks Diagnostics Platform and IgXPLEX Rheumatoid Arthritis Assay for Sale in the ...
SQI Diagnostics Inc. , a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration has cleared the Company's automated SQiDworks Diagnostics Platform and its multiplexed IgXPLEX rheumatoid arthritis assay for marketing in the United States. (Mon, 02 Nov 2009 13:00:00 GMT)
Patrick Soon-Shiong, MD, and Three Healthcare Companies Win 2009 Innovations in Healthcare Awards
Congratulations to the 2009 "Leadership in Innovation" Award Winner Patrick Soon-Shiong, MD, Chairman and CEO of Abraxis Health, as well as the ABBY Award winners announced at ABL Organization's 11th Annual Innovations in HealthcareSM Awards Event this week. They were: Dakim, Inc.; Epocrates, Inc.; and Osmetech Molecular Diagnostics. (Mon, 02 Nov 2009 13:00:00 GMT)
Arrayit Corporation joins federal government in their efforts to help control health care costs
Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform. (Mon, 02 Nov 2009 13:13:49 GMT)
US wonders 'what if'
The new strain of H1N1 flu could have been much more virulent, and it could even have been bird flu. (Mon, 02 Nov 2009 13:20:31 GMT)
Study To Evaluate Genetic Risk Factors For Barrett's Esophagus And Esophageal Adenocarcinoma
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7. (Mon, 02 Nov 2009 13:22:57 GMT)
ISB and Complete Genomics Partner on Huntington's Disease GWAS
NEW YORK (GenomeWeb News) – The Institute for Systems Biology and Complete Genomics said today that they are conducting a joint large-scale human genome sequencing study of Huntington's disease. (Mon, 02 Nov 2009 15:15:32 GMT)
FDA Clears SQI Multiplex Platform, Rheumatoid Arthritis Assay
NEW YORK (GenomeWeb News) – SQI Diagnostics today said that the US Food and Drug Administration has cleared for marketing its SQiDworks multiplex diagnostics platform and IgXPlex rheumatoid arthritis assay. (Mon, 02 Nov 2009 15:45:52 GMT)
Alnylam Releases Preclinical Data Showing Efficacy of TTR Amyloidosis Rx Candidate
Alnylam Pharmaceuticals today released new preclinical data showing that its TTR amyloidosis drug candidate could trigger dose-dependent reductions of liver TTR messenger RNA and serum TTR protein levels by more than 80 percent in transgenic mice and non-human primates. (Mon, 02 Nov 2009 15:46:02 GMT)
ISB and Complete Genomics embark on the largest complete human genome disease association study
The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington’s disease (HD). ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study ... (Mon, 02 Nov 2009 15:59:04 GMT)
Complete Genomics to Sequence 100 Human Genomes for ISB-Led Huntington's Disease Study
Complete Genomics will sequence 100 human genomes for a study of Huntington's disease led by the Institute for Systems Biology, the partners said today. (Mon, 02 Nov 2009 16:15:32 GMT)
Pico-Tesla commences pilot study of its Resonator system for treating type 2 diabetes patients
Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has commenced a randomized, double-blind, placebo-controlled Pilot Study of up to 165 persons who have type 2 diabetes, the most common form of diabetes. (Mon, 02 Nov 2009 16:28:51 GMT)
A new way of looking at the world
What's the first thing that goes through your mind when someone says the word "data"? (Mon, 02 Nov 2009 16:39:47 GMT)
To Know Or Not to Know
People fall into two camps about genetic testing — some people just don't want to know and others are keen to, says Hsien-Hsien Lei at Eye on DNA . She points out a story in the Middletown Journal (Ohio) about a cancer patient who has undergone genetic testing and her family members who are apprehensive about doing it . Another story, Lei points out is that NIH Director Francis Collins was ... (Mon, 02 Nov 2009 17:00:52 GMT)
Changing the Way Researchers Are Trained
"The question is, do we need to rethink how academia functions ?" asks blogger Michael White at Adaptive Complexity. White draws on a recent article from Louis Menand in Harvard Magazine who writes — though he focuses mostly on the humanities — that graduate education is a "lengthy apprenticeship" that doesn't necessarily prepare those students who will be taking jobs outside of academia. (Mon, 02 Nov 2009 17:15:32 GMT)
Mildred Cohn Dies
Mildred Cohn, who pioneered using stable isotopes to trace how enzymes work in cells, has died , reports the Los Angeles Times . She was 96. In addition to her work using stable isotopes to study biochemical reactions, Cohn also used NMR to study the role of ATP as an energy source in the cell. (Mon, 02 Nov 2009 17:15:42 GMT)
Lander at the Darwin Conference
PZ Myers tried to keep up with the Darwin/Chicago 2009 conference on his blog . There, he recounts talks from Jerry Coyne on speciation , Philip Ward on phylogenies , and Eric Lander on genomics and natural selection . At the beginning of Lander's talk, he made the caveat that he wasn't an evolutionist, but rather a biomedical geneticist, which led Myers to comment "as if that was something ... (Mon, 02 Nov 2009 17:15:52 GMT)
Monday, November 2, 2009
Sometimes you have no idea what you are looking for in a gene expression study. You just want to see what is going on and don't want to be limited to what's already known — those unknown genes can have interesting activity too. In that case, an RNAseq experiment might be for you. (Mon, 02 Nov 2009 17:30:42 GMT)
Monday, November 2, 2009
In this issue of GT , we bring you our ninth technical guide on real-time PCR. While it seems like not so long ago that we laid the first troubleshooting lab manual in your hands, the field has advanced, especially in the areas of quality control, experimental design, and data analysis. (Mon, 02 Nov 2009 17:30:52 GMT)
Recent Patents of Interest in Proteomics
US Patent 7,605,003. Use of biomarkers for detecting ovarian cancer . Inventors: Daniel Chan; Zhen Zhang; Eric Fung; Xiao-Ying Meng. Assignees: Johns Hopkins University; Vermillion (Mon, 02 Nov 2009 17:45:32 GMT)
Quest to Offer Septin9 Colorectal Cancer LTD 'Later This Year'
Quest "later this year" plans to begin offering a Septin9 homebrew test for colorectal cancer based on Epigenomics’ mSEPT9 DNA-methylation biomarker, a senior Quest official said today. (Mon, 02 Nov 2009 18:15:33 GMT)
Genomics: No Longer A Failure
Mapping the human genome produced far more hype than drugs. That's starting to change. (Mon, 02 Nov 2009 18:25:12 GMT)
Hutchinson Center Using $8M Grant for Esophageal Cancer Genomics
NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Center has received a $7.9 million grant from the National Cancer Institute to lead a genomics study aimed at finding risk genes for Barrett's esophagus and esophageal adenocarcinoma, a fatal cancer that has increased in incidences 500 percent in the past 30 years. (Mon, 02 Nov 2009 20:00:32 GMT)
High-throughput genotyping, protein purification featured in Cold Spring Harbor Protocols
( Cold Spring Harbor Laboratory ) High-throughput genotyping and protein purification methods are featured in the November issue of Cold Spring Harbor Protocols. (Mon, 02 Nov 2009 20:42:42 GMT)
AACC Grants Proteomics Permanent Status, Signaling Growing Value within Clinical Chemistry
In a move suggesting the growing importance of proteomics in the clinical chemistry arena — and vice versa — the American Association for Clinical Chemistry has made proteomics a permanent division, starting on Jan. 1, 2010. (Mon, 02 Nov 2009 20:45:32 GMT)
Papers of Note
Mahal's lab is focused on the role of glycosylation in myriad biological processes including bacterial pathogenesis, cell signaling, tumor cell metastasis, and neuronal development. Her lab is attempting to develop chemical, biological, and systems-based methods to aid in this research. (Mon, 02 Nov 2009 20:45:42 GMT)
Mike Snyder, Personalized Medicine, Open Access, SBGN, and the 1,000 Genomes Project
In Genome Technology 's cover story five years ago, we looked into the tech transfer process, with our cover image showing off Mike Snyder, who worked with the Yale tech transfer group to start his company Protometrix. The startup was acquired by Invitrogen not long after the story ran. (Mon, 02 Nov 2009 23:30:32 GMT)
ISB Identifies Candidate Disease Genes with Complete Genomics Data
Scientists from the Institute for Systems Biology analyzed the genomes of a four-member family sequenced by Complete Genomics and pinpointed three candidate disease genes for the children, who suffer from rare Mendelian disorders. (Tue, 03 Nov 2009 01:15:32 GMT)
The University Times | The University of North Carolina at Charlotte's Student Newspaper Since 1949
As a student of UNC Charlotte, what does the word ‘expansion’ mean to you? Do you think about the constant construction, the need for more parking, or the limited amount of on-campus housing? (Tue, 03 Nov 2009 05:48:16 GMT)
Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. (Tue, 03 Nov 2009 06:14:01 GMT)
Roche Applied Science to launch the NimbleGen CGX arrays in Europe and Japan
Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop series in four European cities and seven cities in Asia Pacific. The CGX arrays are designed by Signature Genomic Laboratories (Signature Genomics) and provide high-resolution, genome-wide analysis of chromosomal abnormalities. (Tue, 03 Nov 2009 09:59:02 GMT)
Celera licenses lung cancer intellectual property from Medical Therapies
Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited, a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY’s midkine patent portfolio for the development of novel lung cancer diagnostics. (Tue, 03 Nov 2009 10:51:31 GMT)
NuGEN Announces the Newest Member of its Applause Product Family
SAN CARLOS, Calif.----NuGEN Technologies, Inc., a pace-setter in nucleic acid sample preparation, introduces the Applause 3'-Amplification System, a fast, cost-effective, single-tube solution to prepare RNA samples for microarray gene expression studies. (Tue, 03 Nov 2009 11:00:00 GMT)
Rosetta Genomics Names Kenneth A. Berlin President and Chief Executive Officer
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the position of president and chief executive officer, effective November 2, 2009. (Tue, 03 Nov 2009 11:30:00 GMT)
VisualSonics Appoints New President and CEO
VisualSonics Inc., a leader in real time, in vivo, high-resolution micro imaging systems, today announced that the Board of Directors has permanently appointed Anil Amlani, as President and Chief Executive Officer of the Company. (Tue, 03 Nov 2009 12:01:00 GMT)
New study to assess preventative brain radiation therapy for lung cancer patients
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain. (Tue, 03 Nov 2009 12:28:21 GMT)
Akonni Biosystems announces worldwide launch of their TruTip product line
Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more. (Tue, 03 Nov 2009 12:28:50 GMT)
Local Tech Wire
CHAPEL HILL, N.C. — Researchers at the University of North Carolina at Chapel Hill are part of a federally funded team that will conduct a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body. (Tue, 03 Nov 2009 12:49:18 GMT)
Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus ...
CAMBRIDGE, Mass.----Idera Pharmaceuticals, Inc. today presents preclinical data on the mechanism by which IMO-2125 was shown to induce immune activation through Toll-like Receptor 9 . (Tue, 03 Nov 2009 13:00:00 GMT)
Roche NimbleGen Arrays Help Unveil the Secrets of Insidious Potato Blight
MADISON, Wis.----A large international team of researchers recently published the 240-megabase DNA sequence of Phytophthora infestans, a robust parasitic water mold responsible for the Irish potato famine of the 1840s, in Nature . (Tue, 03 Nov 2009 13:00:00 GMT)
Affy Supplying Its 500K Arrays to Public Gene Variant Study
BOSTON, May 5 (GenomeWeb News) - Affymetrix is providing its 500K mapping arrays to an international consortium that is cataloging large-scale gene variants, a consortium leader told GenomeWeb News today. (Tue, 03 Nov 2009 13:16:02 GMT)
Imaging: A Long Time Coming
I think it must’ve been about fifth grade when my class went on a field trip to the American Museum of Natural History in New York to see a fancy new microscope. (Tue, 03 Nov 2009 13:16:12 GMT)
GATC Biotech opens London sequencing lab
Bioinformatics services company, GATC Biotech is to open a sequencing lab at the London BioScience Innovation Centre (LBIC). (Tue, 03 Nov 2009 14:37:30 GMT)
Sigma(R) Life Science Appoints Impress Public Relations as Agency of Record
PHOENIX, AZ--(Marketwire - November 3, 2009) - Impress Public Relations, Inc. today announced that it has been appointed as public relations agency of record by Sigma Life Science , part of the Sigma-Aldrich Corporation and a world leader in innovative products and services serving the global Life Science market. With a global customer base covering pharmaceutical companies, university and ... (Tue, 03 Nov 2009 15:10:30 GMT)
Sigma-Aldrich Licenses Polyplus-transfection's ZNA Technology
NEW YORK (GenomeWeb News) – Sigma-Aldrich said today that it will make and market oligonucleotides developed by Polyplus-transfection, a Strasbourg, France-based firm, under a new worldwide license agreement. (Tue, 03 Nov 2009 15:31:09 GMT)
Reportlinker Adds Preventive Healthcare Technologies, Products and Markets
Reportlinker.com announces that a new market research report is available in its catalogue. (Tue, 03 Nov 2009 16:07:00 GMT)
Taking It High-Throughput
The University of Indiana's Howard Edenberg and Yunlong Liu discuss methods for high-throughput genotyping in the November issue of Cold Spring Harbor Protocols . Their article is excerpted from the Genetics of Complex Human Diseases laboratory manual and, in it, they discuss candidate gene approaches, linkage studies, GWAS, and their follow-up studies. (Tue, 03 Nov 2009 16:30:32 GMT)
Talking Cuts
Johnson and Johnson executives discussed the company's plan to cut six to seven percent of its workforce and Jacob Goldstein at the Wall Street Journal 's Health Blog blogged it live . The cuts, once all in place, are estimated to save the company $1.4 to $1.7 billion a year. (Tue, 03 Nov 2009 16:45:35 GMT)
Choice A or Choice B?
The inaugural post at the Personalized Medicine Coalition's new blog discusses the interplay of personalized medicine and comparative effectiveness . Amy Miller at The Age of Personalized Medicine writes that if "done right, CER could do more to advance personalized medicine than any other policy under consideration right now" but if "done wrong" could set the field back. (Tue, 03 Nov 2009 16:45:54 GMT)
Incyte Genomics
Something missing in our coverage? Thanks for telling us. (Tue, 03 Nov 2009 17:35:41 GMT)
Free and Open Source Bioinformatics Software for Linux
Tech Source From Bohol: "Bioinformatics, as defined by the National Center for Biotechnology Information (BCBI), is the field of science in which biology, computer science, and information technology merge into a single discipline." (Tue, 03 Nov 2009 17:39:03 GMT)
Novartis to Build Largest Pharmaceutical Research & Development Institute in China
BEIJING, China, November 3, 2009 -- Novartis announced today a USD 1 billion investment over the next five years, increasing R&D activities in China and confirming Novartis' long term commitment to China's further economic development, health reform and improving the health care of the Chinese people. (Tue, 03 Nov 2009 18:06:06 GMT)
New Products
Agilent Technologies' SureSelect Human All Exon Kit is now available for use with the Applied Biosystems SOLiD system. The kit enables target enrichment of all human exons and is available in sizes appropriate for studies ranging from few to several thousand samples. (Tue, 03 Nov 2009 18:15:32 GMT)
BGI-Led Project Uses Mix of Illumina and Sanger Sequencing to Assemble Cucumber Genome
Using a combination of Sanger capillary and Illumina sequencing technologies, researchers led by the Beijing Genomics Institute in Shenzhen and the Chinese Academy of Agricultural Sciences in Beijing have sequenced and assembled the genome of the cucumber at a sequencing cost of approximately $3.3 million. (Tue, 03 Nov 2009 19:00:35 GMT)
GATC Biotech to Open UK Sequencing Lab in 2010
Sequencing service provider GATC Biotech of Constance, Germany, said this week that it plans to open a sequencing laboratory in London early next year in order to provide its customers in the UK and in Ireland with single-sample sequencing services. (Tue, 03 Nov 2009 19:15:32 GMT)
Miami or Bust
The story of the John P. Hussman Institute for Human Genomics at the University of Miami Miller School of Medicine actually began at Duke University, where the institute's director, Margaret Pericak-Vance, was formerly the director of Duke's Center for Human Genetics. (Tue, 03 Nov 2009 19:45:42 GMT)
Biotech breathes new life
Manufacturing takes on a whole new meaning when speaking of biotechnology; it is a different game with a new book of rules than traditional pharmaceutical manufacturing. (Tue, 03 Nov 2009 20:03:54 GMT)
UK, Germany, Netherlands Give $2.5M for Plant Systems Biology Effort
NEW YORK (GenomeWeb News) – Researchers at universities in the UK, Germany, and the Netherlands will use €1.7 million ($2.5 million) to conduct systems biology and informatics-based studies of plant seed germination, according to the University of Freiburg. (Tue, 03 Nov 2009 20:30:32 GMT)
Link Technologies Inks Licensing Deal with RiboTask
NEW YORK (GenomeWeb News) – Reagents maker Link Technologies said today that it will sell RiboTask's nucleic acid monomers, under a new license agreement. (Tue, 03 Nov 2009 20:30:42 GMT)
NIH Awards $67M in EUREKA Grants
NEW YORK (GenomeWeb News) – The National Institutes of Health has granted $67.4 million in funding for trailblazing research that could reap great benefits but which are not guaranteeing immediate results, including genomics and proteomics studies, NIH said Monday. (Tue, 03 Nov 2009 21:00:35 GMT)
Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 11 Percent
HERCULES, CA--(Marketwire - November 3, 2009) - Bio-Rad Laboratories, Inc. ( NYSE : BIO ) and ( NYSE : BIO.B ), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the third quarter ended September 30, 2009. Third-quarter reported revenues were $461.1 million, up 4.4% compared to $441.8 million reported for ... (Tue, 03 Nov 2009 21:39:50 GMT)
IP Roundup
Sandia Corp. of Livermore, Calif., a contractor that manages Sandia National Laboratories, has received US Patent No. 7,611,834, "Methods and devices for protein assays." The patent claims methods and devices for protein assays based on Edman degradation in microfluidic channels. (Tue, 03 Nov 2009 22:15:32 GMT)
New Product Watch
Akonni Biosystems this week launched TruTip , a tool for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more. (Tue, 03 Nov 2009 22:15:42 GMT)
Progenika Inks Companion-Dx Deal with AMT, Service Pact with ARUP Labs
Spanish biotech firm Progenika Biopharma recently announced two separate deals to make its array technology and expertise available to partners. (Tue, 03 Nov 2009 22:45:32 GMT)
In Print
Title: Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities. (Tue, 03 Nov 2009 22:45:42 GMT)
FDA Clears SQI Diagnostics' Array-Based RA Test for Sale in US
SQI Diagnostics said this week that the US Food and Drug Administration has cleared for marketing its SQiDworks multiplex diagnostics platform and IgXPlex rheumatoid arthritis assay. (Tue, 03 Nov 2009 23:00:43 GMT)
Illumina Files Patent Infringement Suit Against Affymetrix
NEW YORK (GenomeWeb News) – Illumina has filed a lawsuit against Affymetrix alleging that a variety of its GeneChip products infringe a patent that was issued to Illumina today. (Wed, 04 Nov 2009 00:00:39 GMT)
Monsanto Biotechnology Research Center established in China
Monsanto Company (NYSE: MON) announced today that it is opening its first research center in China, further demonstrating its commitment to forming technology collaborations in the country. (Wed, 04 Nov 2009 08:29:13 GMT)
The Clinical Case for Array CGH
Clinicians have known for years that chromosomal structural changes can be related to disease, and thanks to high-resolution microarrays for probing SNPs and CNVs across the genome, scientists have been able to catalog more and more of these. (Wed, 04 Nov 2009 09:30:32 GMT)
CombiMatrix Corporation to Release Third Quarter Financial Results on November 11, 2009
MUKILTEO, Wash. -- CombiMatrix Corporation announced today that it will release its third quarter 2009 financial results on Wednesday, November 11, 2009. Results will be released at the close of trading on that day. (Wed, 04 Nov 2009 11:00:00 GMT)
Turning research into practicality is focus of Roswell Park workshop
About 100 research scientists and life science industry professionals gathered Tuesday in Roswell Park Cancer Institute to take another step in the quest to help researchers bring medical discoveries out of the academic realm and into real-world application. (Wed, 04 Nov 2009 12:23:43 GMT)
Genetic Privacy, BioAnalytics Group, BioSoftware Systems, Genomatica, Jubilant Biosys, Strand Genomics, Compugen, Gene ...
In a Policy Forum article in the July 9 issue of Science , Russ Altman and colleagues at Stanford University argued that unencumbered access to genomic data raises unforeseen privacy issues, and that current attempts to protect genetic data are inadequate. (Wed, 04 Nov 2009 13:15:32 GMT)
BioArray Software Environment (BASE)
Researchers from Lund University in Sweden and Columbia University College of Physicians and Surgeons have been working on a web-based platform for storing, sharing, and analyzing array data, which they have named BioArray Software Environment (BASE) . The group, including Lao Saal, Carl Troein, and Johan Vallon-Christersson, is planning to make BASE available and free to academics, with open ... (Wed, 04 Nov 2009 13:15:42 GMT)
$400 Million? Drop in the Bucket
The Broad Institute's big announcement this morning is that Eli and Edythe Broad will be giving the institute $400 million and will be making its 10-year experiment as a genomic research center permanent. (Wed, 04 Nov 2009 13:15:52 GMT)
A Fight Worth Watching: Systems Biology vs. Metastates
MIT broke ground on a new cancer center last week, the David H. Koch Institute for Integrative Cancer Research , which will bring scientists and engineers together to study cancer metastates. (Wed, 04 Nov 2009 13:16:02 GMT)
Biosearch Technologies Licenses H1N1 Flu IP from CDC
NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed H1N1 influenza signatures and the influenza A sub-typing panel signatures from the Centers of Disease Control and Prevention. (Wed, 04 Nov 2009 15:00:32 GMT)
Mayo's Cortese stays focused on health
The departing national CEO of Mayo Clinic does not plan to rest on his laurels when he retires later this month (Wed, 04 Nov 2009 15:18:19 GMT)
Grain News
St. Louis and Beijing— Monsanto Company announced Nov. 4 that it is opening its first research center in China, further demonstrating its commitment to forming technology collaborations in the country. (Wed, 04 Nov 2009 15:41:27 GMT)
Minding the Gate
In an open letter to physicians, brought on by an email exchange with Steve Murphy, regarding direct-to-consumer genomics and personalized medicine, blogger William Gunn says that many laws regarding regulation of medical tests were written when people didn't want to see raw data and when tests weren't so accurate. (Wed, 04 Nov 2009 17:30:49 GMT)
NSF awards $20 million to SDSC to develop 'Gordon'
( University of California - San Diego ) The San Diego Supercomputer Center (SDSC) at UC San Diego has been awarded a five-year, $20 million grant from the National Science Foundation to build and operate a powerful supercomputer dedicated to solving critical science and societal problems now overwhelmed by the avalanche of data generated by the digital devices of our era. (Wed, 04 Nov 2009 18:31:08 GMT)
More on return of research data to participants from Genomics Law Report [Genetic Future]
Yesterday I posted a brief rant about the need for researchers to think about the best way to return genetic research data to participants, spinning off an equally brief opinion piece I wrote for the ongoing ELSI series at Genomics Law Report . Today Dan Vorhaus has posted an excellent piece on the same topic over at GLR, triggered by an exchange between 23andMe's Anne Wojcicki and Kaiser ... (Wed, 04 Nov 2009 18:32:55 GMT)
NSF Awards $20 Million to SDSC to Develop "Gordon" Supercomputer
Supercomputer will use flash to solve data-intensive problems 10 times faster than current solutions National Science Foundation - San Diego Supercomputer Center - United States - Government - Senate (Wed, 04 Nov 2009 19:41:06 GMT)
Monsanto Opening Beijing Genomics, Biotech Center
NEW YORK (GenomeWeb News) – Monsanto said today that it will open a research center in Beijing that will focus on collaborations with Chinese research institutions in plant biotechnology and genomics research. (Wed, 04 Nov 2009 19:45:32 GMT)
GIS-Led Team Publishes Method for Mapping Genome-Wide Chromatin Interactions
NEW YORK (GenomeWeb News) – Researchers from Singapore and the Netherlands reported in Nature today that they successfully used their ChIA-PET method to map the estrogen receptor alpha-related chromatin interactome in human breast cancer cells. (Wed, 04 Nov 2009 20:01:02 GMT)
Luminex Corporation Reports Third Quarter 2009 Results
AUSTIN, Texas----Luminex Corporation today announced financial results for the third quarter ended September 30, 2009. Recent financial and operating highlights include the following: Record system shipments of 259, including 11 FLEXMAP 3D® systems for the third quarter of 2009, resulting in cumulative life-to-date shipments of 6,514, up 15 percent from a year ago Record system revenue of $9.2 ... (Wed, 04 Nov 2009 21:01:00 GMT)
Monsanto opening first research center in China
Monsanto Co., the world's biggest seed maker, on Tuesday said it is opening its first research center in China. The Monsanto Biotechnology Research Center in Beijing will boost Monsanto's ties with Chinese research institutions in plant biotechnology and genomics. (Wed, 04 Nov 2009 21:25:53 GMT)
Your North Lake County Calendar
Find out all the events going on in your community, and plan your week's activities with The Times. (Wed, 04 Nov 2009 22:15:03 GMT)
Large Hadron Collider team flicks switch on Xeon grid
The Register: "CERN today unveiled the upgraded grid that will support the Large Hadron Collider when the titanic particle-punisher finally kicks back into life." (Thu, 05 Nov 2009 01:38:10 GMT)
Lonza acquires Belgium-based contract research firm Algonomics
Lonza strengthens its protein design technology offering for biopharmaceutical development by acquiring Algonomics NV (Gent, Belgium). Algonomics is a contract research organisation providing integrated immunogenicity prediction services to support companies in the development of biotherapeutics. (Thu, 05 Nov 2009 03:51:25 GMT)
Novartis to invest US$ 1 bn to build largest pharma R&D institute in China
Novartis announced a USD 1 billion investment over the next five years, increasing R&D activities in China and confirming Novartis' long term commitment to China's further economic development, health reform and improving the health care of the Chinese people. (Thu, 05 Nov 2009 04:51:25 GMT)
Future of Food
Future students might enjoy shorter lines and more food choices if Carolina Dining Services acts on recent proposals. (Thu, 05 Nov 2009 06:14:44 GMT)
QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing
VENLO, Netherlands----QIAGEN today announced an expansion of its strategic partnership with the United Kingdom’s Veterinary Laboratories Agency , one of the world’s leading research institutions in veterinary science. (Thu, 05 Nov 2009 07:30:00 GMT)
Future of Food
Future students might enjoy shorter lines and more food choices if Carolina Dining Services acts on recent proposals. (Thu, 05 Nov 2009 08:44:54 GMT)
Kamla Nehru College convention on pharmaceutical sciences from Nov 22
The Kamla Nehru College of Pharmacy, Nagpur, one of the leading pharmacy colleges in Vidharbha region, is organising a two -day national level convention 'Recent advances in pharmaceutical sciences and drug discovery' on November 22 and 23, 2009 and two weeks staff development programme , 'Emerging trends in drug discovery and quality assurance' from November 24 to December 7, 2009. (Thu, 05 Nov 2009 10:06:25 GMT)
Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments
SUNNYVALE, CA--(Marketwire - 11/05/09) - Arrayit Corporation (OTC.BB: ARYC - News ) is pleased to join the federal government in their efforts to help control health care costs through early diagnosis of diseases. For more than 150 years, traditional medicine has relied on a 'standards of care' model, which utilizes large cohorts of individuals as the data set and essentially treats every person ... (Thu, 05 Nov 2009 12:00:00 GMT)
Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments
Collaborative Efforts Leading to Advances That Will Contribute to Health Care Reform (Thu, 05 Nov 2009 12:10:36 GMT)
Rosetta Genomics Strengthens MicroRNA Intellectual Property Position with Receipt of Additional Patent
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office has issued U.S. (Thu, 05 Nov 2009 12:30:00 GMT)
Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new data related to its overall delivery research efforts including the rational design of Mimetic Lipoprotein Particles, or MLPs, a novel technology for the systemic delivery of small interfering RNAs, or siRNAs, the molecules that mediate RNAi. (Thu, 05 Nov 2009 12:44:27 GMT)
Illumina Announces Scale-Up of Genome Analyzers at The Broad Institute
SAN DIEGO----Illumina, Inc. today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89. (Thu, 05 Nov 2009 13:00:00 GMT)
MDRNA, Inc. to Hold Third Quarter 2009 Results Conference Call on Thursday, November 12, 2009 at 4:30 pm Eastern Time
BOTHELL, WA--(Marketwire - November 5, 2009) - MDRNA, Inc. ( NASDAQ : MRNA ) announced today that it will host a conference call with investors and security analysts on Thursday, November 12, 2009, at 4:30 pm Eastern Time (1:30 pm Pacific Time) to provide a business update and discuss financial results for the 3rd quarter ended September 30, 2009. To participate in the live conference call, U.S ... (Thu, 05 Nov 2009 13:09:36 GMT)
Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion Diagnostic
VANCOUVER, November 5 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). (Thu, 05 Nov 2009 13:14:21 GMT)
Susan Strong, Mary Ann Guerra, Haseeb Chaudhry, Darryl Ray, Kalypsys Integrated Screening Systems, Ibidi s -Dish, and ...
Fisher subsidiary Dharmacon has hired Susan Strong as vice president of marketing, CBA News learned last week. Mary Ann Guerra has been promoted to chief operating officer of the Translational Genomics Research Institute of Phoenix, Ariz., TGen said last week. (Thu, 05 Nov 2009 13:15:42 GMT)
GeneData to Provide Phylosopher Software to Japanese Institute
NEW YORK, March 19 – GeneData, a Swiss bioinformatics company, said Monday it would provide its Phylosopher software for comparative genomics studies to the Japanese National Institute of Technology and Evaluation. (Thu, 05 Nov 2009 13:15:52 GMT)
New Crop of AgBioinformatics Projects Accompanies Publication of Rice Genome
Last week’s publication of the indica and japonica subspecies of the rice genome by the Beijing Genomics Institute and Syngenta, respectively, was heralded as a milestone for agricultural genomics. (Thu, 05 Nov 2009 13:16:12 GMT)
National Institutes of Health Award Northrop Grumman Bioinformatics Resource Centers Contract
RESTON, Va. -- Northrop Grumman Corporation has been awarded a follow-on contract by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to create a resource that supports research of pathogenic viruses and that will lead to new medical treatments and preventive measures for humans. (Thu, 05 Nov 2009 13:30:00 GMT)
Market Pulse Breaking News Alert for Thursday, November 5, 2009: ARYC -- Arrayit Corporation to Diagnose Early Stage ...
ATLANTA, GA--(Marketwire - 11/05/09) - Market Pulse News Alert for this AM, Stocks to Watch are: Arrayit Corporation (OTC.BB: ARYC - News ), Merck & Co. Inc. (NYSE: MRK - News ), ON Semiconductor Corp. (NASDAQ: ONNN - News ) and American Lithium Minerals Inc. (OTC.BB: AMLM - News ). Investors need to be watching Arrayit Corporation (OTC.BB: ARYC - News ) this AM! Arrayit Corporation is engaged ... (Thu, 05 Nov 2009 13:30:00 GMT)
Sweetpotatoes Get High-Tech Help
An Agricultural Research Service (ARS) computational molecular biologist in Mississippi is launching a project to create a genomics toolkit to help plant breeders develop new varieties of sweetpotato. (Thu, 05 Nov 2009 13:33:58 GMT)
Market Pulse Breaking News Alert for Thursday, November 5, 2009: ARYC -- Arrayit Corporation to Diagnose Early Stage ...
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse (Thu, 05 Nov 2009 13:41:18 GMT)
(AFX UK Focus) 2009-11-05 13:59 BRIEF-Northrop Grumman gets follow-on contract from National Institutes of Health
Nov 5 (Reuters) - Northrop Grumman Corp: (Thu, 05 Nov 2009 14:12:25 GMT)
Singularity University Prepares Executives for Impact of Exponentially Accelerating Technologies
New Nine-Day Executive Program Focuses on How to Harness Current and Future Disruptive Technologies to Benefit Companies and Industries; World-Class Faculty and Innovative Interdisciplinary Curriculum Establish New Model for Executive Education; Silicon Valley Software Leader Joins University as First Corporate Partner (Thu, 05 Nov 2009 14:12:47 GMT)
Stimulus grant to help MSU team improve drug development from plants
( Michigan State University ) Scientists at Michigan State University are receiving nearly $3 million from the National Institutes of Health to uncover how several popular plants make medicinal compounds. (Thu, 05 Nov 2009 16:36:17 GMT)
Complete Genomics Publishes in Science on Low-Cost Sequencing of Three Human Genomes Using Its Proprietary Sequencing ...
MOUNTAIN VIEW, Calif.----Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. (Thu, 05 Nov 2009 19:00:00 GMT)
Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes
( Complete Genomics ) Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8 ... (Thu, 05 Nov 2009 19:27:58 GMT)
Complete Genomics Gets Cost of Gene Sequencing Under $5,000
Nov. 5 (Bloomberg) -- Complete Genomics , a closely held company in Silicon Valley, produced complete sequences of three people’s DNA at an average cost of $4,500, accelerating the race to develop faster, cheaper gene-mapping systems. (Thu, 05 Nov 2009 19:29:13 GMT)
NCI Papers Describe Yeast Reference Standard, LC-MS Benchmarking Metrics
As part of its ongoing effort to evaluate mass spectrometry-based platforms for unbiased discovery work in proteomics, members of the National Cancer Institute's initiative on clinical proteomics last month published work meant to help researchers in the field better assess their instrument platforms. (Thu, 05 Nov 2009 20:00:32 GMT)
Complete Genomics reports low-cost sequencing of 3 human genomes
Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8,005 for 87x coverage ... (Thu, 05 Nov 2009 20:05:50 GMT)
USDA Funding Sweet Potato Chip
NEW YORK (GenomeWeb news) – The US Department of Agriculture is funding genomics research into sweet potatoes that could help plant breeders develop new varieties, and has awarded $120,000 to support a post-graduate research position. (Thu, 05 Nov 2009 20:30:52 GMT)
NCBI's Dilemma: Updating Human Reference Genome without Disrupting Research
The National Center for Biotechnology Information is currently mulling ways to close gaps, add annotation, and possibly release patches to the human reference sequence genome while causing minimal disruption to the scientific community that relies on this resource, an NCBI official said at a recent meeting. (Thu, 05 Nov 2009 20:31:12 GMT)
Complete Genomics Publication Outlines Results for Three Human Genomes
NEW YORK (GenomeWeb News) – Researchers from Complete Genomics, Harvard Medical School and Washington University in St. Louis today reported on three of the human genomes that they have sequenced using Complete Genomics' nanoarray technology. (Thu, 05 Nov 2009 20:45:32 GMT)
At Genome Informatics, Speakers Say Second-Gen Sequencing Makes for Giddy Times for Bioinformatics
Talks and posters at this year's Genome Informatics meeting highlighted how second-generation sequencing is setting the pace for bioinformatics as scientists race to fill a widening gap between the capabilities of these instruments and the tools required to analyze and manage the data. (Thu, 05 Nov 2009 20:45:42 GMT)
Complete Genomics Gets Gene Sequencing Under $5,000 (Correct)
(Corrects number of gene studies in fourth paragraph.) Nov. 5 (Bloomberg) -- Complete Genomics , a closely held company in Silicon Valley, produced complete sequences of three people’s DNA at an average cost of $4,500, accelerating the race to develop faster, cheaper gene-mapping systems. (Thu, 05 Nov 2009 21:44:13 GMT)
Complete Genomics Gets Gene Sequencing Under $5,000 (Update1)
Nov. 5 (Bloomberg) -- Complete Genomics , a Silicon Valley company backed by venture capitalists, produced complete sequences of three people’s DNA at an average cost of $4,500, accelerating the race to develop faster, cheaper gene-mapping systems. (Thu, 05 Nov 2009 21:59:29 GMT)
Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide
( Cold Spring Harbor Laboratory ) As global temperatures and energy costs continue to soar, renewable sources of energy will be key to a sustainable future. An attractive replacement for gasoline is biofuel, and in two studies published online in Genome Research, scientists have analyzed the genome structures of bioethanol-producing microorganisms, uncovering genetic clues that will be critical ... (Thu, 05 Nov 2009 22:17:03 GMT)
Horse genome sequenced
An international project has provided the first complete genetic sequence of the horse, providing resources to track horse-related genetic diseases and to understand horse biology. (Thu, 05 Nov 2009 23:05:49 GMT)
Your South Lake County Calendar
Find out all the events going on in your community, and plan your week's activities with The Times. (Thu, 05 Nov 2009 23:25:02 GMT)
Complete Genomics Details Low-Cost Sequencing Tech in Paper; Collaborators Encouraged by Results
Nine month after presenting human genome sequencing data generated on its proprietary sequencing platform for the first time, Complete Genomics today published a detailed description of its technology in Science , applying it to sequence three human genomes at a consumables cost of between $1,700 and $8,000 per genome. (Thu, 05 Nov 2009 23:45:32 GMT)
Your North Lake County Calendar
Find out all the events going on in your community, and plan your week's activities with The Times. (Fri, 06 Nov 2009 00:03:16 GMT)
Illumina Inc. Reports Operating Results (10-Q)
By 10qk. Illumina Inc. ( ILMN ) filed Quarterly Report for the period ended 2009-09-27. Read more » » (Fri, 06 Nov 2009 00:29:44 GMT)
UQ researchers first in the world to solve the genetic code of canola
Until recently, the genetic code of canola was a mystery. (Fri, 06 Nov 2009 02:05:24 GMT)
Complete Genomics publishes sequence analysis data from three complete human genomes
Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8,005 for 87x coverage ... (Fri, 06 Nov 2009 06:13:50 GMT)
Sirius Genomics signs its first Contribution Agreement with NRC-IRAP
Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP). This research funding will be used to study genomic correlations in severe sepsis patients. (Fri, 06 Nov 2009 07:14:00 GMT)
Broad Institute purchases 30 additional Genome Analyzers from Illumina
Illumina, Inc. today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89. (Fri, 06 Nov 2009 08:29:26 GMT)
USPTO issues patent for Rosetta Genomics' human microRNA miR-193b
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO. (Fri, 06 Nov 2009 08:44:00 GMT)
Stanford University is undertaking its biggest building boom ever, with 87 projects worth $1.5 billion under ...
Due to gifts from donors, Stanford University is undertaking its biggest building boom ever, with 87 projects worth $1.5 billion in design or under construction.A dramatic decline in its endowment caused the campus to suspend about $1.3 billion in planned projects.But long-ago commitments from donors like Nike founder and Stanford alum Phil Knight means that 2009 is the biggest year in Stanford ... (Fri, 06 Nov 2009 10:14:18 GMT)
1 2 3 4 5 Next
